It has antipyretic, brain tissue protective and liver damage resistance effects

It has antipyretic, brain tissue protective and liver damage resistance effects

It has antipyretic, brain tissue protective and liver damage resistance effects

It has antipyretic, brain tissue protective and liver damage resistance effects

It has antipyretic, brain tissue protective and liver damage resistance effects

It has antipyretic, brain tissue protective and liver damage resistance effects

It has antipyretic, brain tissue protective and liver damage resistance effects

It has antipyretic, brain tissue protective and liver damage resistance effects

As the precursor of oxaloacetate in the body, it plays an important role in the tricarboxylic acid cycle and participates in the ornithine cycle, combining ammonia and carbon dioxide to form urea. It has a strong affinity for cells and can be used as a carrier of potassium and magnesium ions to help them enter cells, increase the concentration of potassium and magnesium in cells, accelerate the tricarboxylic acid cycle of liver cells, and have a certain effect on improving liver function and reducing serum bilirubin concentration. It is metabolized and excreted from the body through the kidneys.

As a potassium ion carrier, it helps potassium ions enter cells, increases the concentration of potassium and magnesium in cells, accelerates the tricarboxylic acid cycle of liver cells, and has a certain effect on improving liver function and reducing serum bilirubin concentration. It is metabolized and excreted from the body through the kidneys.

As a magnesium ion carrier, it helps magnesium ions enter cells, increases the concentration of potassium and magnesium in cells, accelerates the tricarboxylic acid cycle of liver cells, and plays a certain role in improving liver function and reducing serum bilirubin concentration. It is metabolized and excreted from the body through the kidneys.

No specific description provided

It has antiprotozoan and obligate anaerobic effects. It has inhibitory effects on protozoa such as Trichomonas vaginalis, Entamoeba histolytica and Giardia lamblia. It has antibacterial effects on most anaerobic bacteria such as Bacteroides fragilis, Bacteroides melanin, other Bacteroides, Clostridium, Eubacteria, Fusobacterium, Haemophilus vaginalis, Peptococcus, Peptostreptococcus and Veillonella.

It has a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacteria, and has antibacterial activity against most bacteria of the Enterobacteriaceae family, penicillin-resistant Neisseria gonorrhoeae, enzyme-producing influenza bacilli and Moraxella, Pseudomonas aeruginosa, etc. It has antibacterial activity against methicillin-sensitive Staphylococci, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus, and Enterococcus faecalis. It has good antimicrobial effects against Chlamydia trachomatis, Mycoplasma, and Legionella, and also has antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. It has poor antibacterial activity against anaerobic bacteria. Ciprofloxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death.